Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Sho-saiko-to "helped to prevent" hepatocellular carcinomas -- Cancer study.

This article was originally published in The Tan Sheet

Executive Summary

CHINESE SHO-SAIKO-TO "HELPED TO PREVENT" LIVER CANCER, researchers from Osaka City University Medical School, Osaka City General Hospital, Sumiyoshi Municipal Hospital, Kobe Asahi Hospital and the Institute of Public Health in Tokyo report in the Sept. 1 issue of Cancer. Hiroko Oka et al. concluded that the Chinese herbal remedy Sho-saiko-to (TJ-9) "helped to prevent the development of hepatocellular carcinomas in patients with cirrhosis, particularly in patients without [hepatitis B] antigen." Hepatocellular carcinoma (HCC) is a common cancer, often found in patients with underlying cirrhosis.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel